liver disease mash - Search News

News

GSK to buy liver disease drug from Boston Pharmaceuticals

GSK to buy experimental MASH drug for $1.2B upfront

GSK plans to purchase an experimental drug for the liver disease MASH from Boston Pharmaceuticals for $1.2 billion upfront.

Reuters on MSN · 5h

GSK to buy liver disease drug for up to $2 billion

GSK will buy efimosfermin, a liver disease drug in late-stage trials, for up to $2 billion from U.S. biotechnology firm Boston Pharmaceuticals, the British drugmaker said on Wednesday. Efimosfermin, a monthly subcutaneous injection,

BioPharma Dive · 4h

GSK to buy liver disease drug for $1.2B

The new acquisition from Boston Pharmaceuticals adds to a wave of dealmaking undertaken by GSK to build its liver disease franchise.

Health on MSN4d

Road to Diagnosis: I Had No Symptoms for Years, but MASH Was Damaging My Liver

Fact checked by Nick Blackmer I was first told that I was at higher risk for fatty liver disease in 2005. I had never heard ...

How to protect your liver from the MASH threat danger

Discover how metabolic dysfunction-associated steatohepatitis (MASH) damages your liver, its connection to common health ...

11don MSN

Semaglutide found to have shocking benefit for liver disease patients in new study

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

Health on MSN1d

Ozempic Shows Promise in Treating a Severe Form of Liver Disease, Study Finds

A new study suggests that semaglutide, the active ingredient in Ozempic, may help decrease liver fat, inflammation, and ...

MyChesCo on MSN2d

Madrigal Pharmaceuticals Reports Promising Two-Year Data for Rezdiffra in MASH Cirrhosis

CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) has announced two-year results from the open-label arm of ...

Semaglutide Therapy Improves Liver Histology in MASH

GLP-1 RA helped resolution of steatohepatitis without worsening fibrosis and reduced liver fibrosis without worsening steatohepatitis.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results